Type 2 diabetes, atherosclerosis, non-alcoholic steatohepatitis… Therapeutic approaches able to limit obesity-related comorbidities are still cruelly lacking in medicine. Extracellular vesicles are starting to emerge as major effectors in their early mechanisms. These could represent predictive biomarkers for cardiovascular complications of obesity, or even targets for their prevention.

Tue 13 Nov 2018 – 17:15